These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33649299)

  • 21. Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.
    Klumpp-Thomas C; Kalish H; Hicks J; Mehalko J; Drew M; Memoli MJ; Hall MD; Esposito D; Sadtler K
    J Infect Dis; 2021 Mar; 223(5):802-804. PubMed ID: 33257936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
    Gobeil SM; Janowska K; McDowell S; Mansouri K; Parks R; Manne K; Stalls V; Kopp MF; Henderson R; Edwards RJ; Haynes BF; Acharya P
    Cell Rep; 2021 Jan; 34(2):108630. PubMed ID: 33417835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Díaz Y; Ortiz A; Weeden A; Castillo D; González C; Moreno B; Martínez-Montero M; Castillo M; Vasquez G; Sáenz L; Franco D; Pitti Y; Chavarria O; Gondola J; Moreno AM; Ábrego L; Beltrán D; Guerra I; Chang J; Chaverra Z; Guerrero I; Valoy A; Gaitán M; Araúz D; Morán E; Chen-Germán M; Valdespino E; Rodríguez R; Corrales R; Chen-Camaño R; Pascale JM; Martínez AA; López-Vergès S;
    Int J Infect Dis; 2021 Jul; 108():588-591. PubMed ID: 34107326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
    Gupta AM; Chakrabarti J; Mandal S
    Microbes Infect; 2020; 22(10):598-607. PubMed ID: 33049387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2.
    Parsons E; Timlin M; Starr C; Fries A; Wells R; Studer M; Sainato R
    J Pediatric Infect Dis Soc; 2021 May; 10(5):695-697. PubMed ID: 33336251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.
    González-Puelma J; Aldridge J; Montes de Oca M; Pinto M; Uribe-Paredes R; Fernández-Goycoolea J; Alvarez-Saravia D; Álvarez H; Encina G; Weitzel T; Muñoz R; Olivera-Nappa Á; Pantano S; Navarrete MA
    Viruses; 2021 May; 13(5):. PubMed ID: 34064904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
    Guo S; Liu K; Zheng J
    Int J Biol Sci; 2021; 17(6):1476-1485. PubMed ID: 33907511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.
    von Bartheld CS; Hagen MM; Butowt R
    ACS Chem Neurosci; 2021 Oct; 12(19):3535-3549. PubMed ID: 34533304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding.
    Niu Z; Zhang Z; Gao X; Du P; Lu J; Yan B; Wang C; Zheng Y; Huang H; Sun Q
    Signal Transduct Target Ther; 2021 Jul; 6(1):284. PubMed ID: 34315847
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.
    Kwarteng A; Asiedu E; Sylverken AA; Larbi A; Sakyi SA; Asiedu SO
    Infect Genet Evol; 2021 Jul; 91():104815. PubMed ID: 33774178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Kulkarni O; Narreddy S; Zaveri L; Kalal IG; Tallapaka KB; Sowpati DT
    Clin Infect Dis; 2021 Sep; 73(5):e1239-e1241. PubMed ID: 34492695
    [No Abstract]   [Full Text] [Related]  

  • 35. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.
    Ilmjärv S; Abdul F; Acosta-Gutiérrez S; Estarellas C; Galdadas I; Casimir M; Alessandrini M; Gervasio FL; Krause KH
    Sci Rep; 2021 Jul; 11(1):13705. PubMed ID: 34210996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
    Mak GCK; Lau AWL; Chan AMY; Chan DYW; Tsang DNC
    J Clin Virol; 2020 Sep; 130():104550. PubMed ID: 32763812
    [No Abstract]   [Full Text] [Related]  

  • 38. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).
    Nguyen TT; Pathirana PN; Nguyen T; Nguyen QVH; Bhatti A; Nguyen DC; Nguyen DT; Nguyen ND; Creighton D; Abdelrazek M
    Sci Rep; 2021 Feb; 11(1):3487. PubMed ID: 33568759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
    SeyedAlinaghi S; Mirzapour P; Dadras O; Pashaei Z; Karimi A; MohsseniPour M; Soleymanzadeh M; Barzegary A; Afsahi AM; Vahedi F; Shamsabadi A; Behnezhad F; Saeidi S; Mehraeen E; Shayesteh Jahanfar
    Eur J Med Res; 2021 Jun; 26(1):51. PubMed ID: 34103090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.